Eli Lillys weight loss pill, Orforglipron, is still awaiting FDA-approval and is expected by the summer of 2026
It works best when its coordinated with a clear understanding of what it can do weight, metabolism, airway fat and what it cant skeletal correction, structural joint repair, real airway reconstruction
In addition, the SUSTAIN 6 trial demonstrated a significant reduction in major CV events with semaglutide versus placebo in patients with T2D at high CV risk
In both studies, participants randomly received either 10 or 15 milligrams of Zepbound or placebo once weekly for 52 weeks
Pharmacologic GLP-1 receptor agonists mimic this hormone, helping patients achieve significant weight loss and improved blood sugar regulation